Melatonin, a naturally occurring hormone commonly used to treat insomnia, is being investigated for a possible role in relieving chronic pain. The articles report on a new study finding that melatonin could help reduce chronic pain symptoms, potentially lowering reliance on painkillers that may carry health risks. The coverage notes that melatonin is relatively inexpensive, described as a low-cost “50p pill,” yet remains difficult to obtain in the UK. The sources focus on the apparent gap between melatonin’s affordability and its availability, raising questions about why patients cannot easily access it despite existing use for sleep disorders. While the study’s results are presented as promising, the articles do not provide additional details such as the study size, patient groups, or whether melatonin is recommended for chronic pain as part of current clinical guidelines. Overall, the reports highlight both the potential therapeutic benefit suggested by the research and the practical barrier of limited access in the UK.